Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.54 is 46% above its 2-year average of -1.00, near the high end of its 2-year range (-1.93–0.03).
64.36% above its 12-month average of -1.52.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.29.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 6 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:47:54.249Z. Historical observations retain their original dates. Historical series through 2025-03-27.
EARNINGS PER SHARE (EPS)
-0.54
EARNINGS PER SHARE (EPS) AVG TTM
-1.52
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+64.36%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.63B
Earnings Per Share (EPS)
-0.72
TTM Avg
-1.04
3Y Avg
-1.27
5Y Avg
-1.30
Market Cap
$1.63B
Earnings Per Share (EPS)
-1.42
TTM Avg
-1.32
3Y Avg
-1.19
5Y Avg
-1.40
Market Cap
$1.62B
Earnings Per Share (EPS)
4.63
TTM Avg
1.23
3Y Avg
0.09
5Y Avg
-0.82
Market Cap
$1.61B
Earnings Per Share (EPS)
0.84
TTM Avg
0.16
3Y Avg
0.00
5Y Avg
0.42
Market Cap
$1.61B
Earnings Per Share (EPS)
-2.67
TTM Avg
-2.43
3Y Avg
-2.07
5Y Avg
-2.07
Market Cap
$1.61B
Earnings Per Share (EPS)
-4.04
TTM Avg
-4.19
3Y Avg
-4.39
5Y Avg
-2.20
Market Cap
$1.69B
Earnings Per Share (EPS)
-9.62
TTM Avg
-6.10
3Y Avg
-4.07
5Y Avg
-4.07
Market Cap
$1.57B
Earnings Per Share (EPS)
-3.36
TTM Avg
-0.89
3Y Avg
-1.69
5Y Avg
-1.77
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Septerna Inc (SEPN) | $1.63B | -0.54 | -1.52 | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.63B | -0.72 | -1.04 | -1.27 | -1.30 |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.63B | -1.42 | -1.32 | -1.19 | -1.40 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.62B | 4.63 | 1.23 | 0.09 | -0.82 |
| Omnicell, Inc. (OMCL)vs › | $1.61B | 0.84 | 0.16 | 0.00 | 0.42 |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | -2.67 | -2.43 | -2.07 | -2.07 |
| uniQure N.V. (QURE)vs › | $1.61B | -4.04 | -4.19 | -4.39 | -2.20 |
| Zenas BioPharma, Inc. (ZBIO)vs › | $1.69B | -9.62 | -6.10 | -4.07 | -4.07 |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | -3.36 | -0.89 | -1.69 | -1.77 |
| Personalis, Inc. (PSNL)vs › | $1.70B | -1.09 | -1.14 | -1.75 | -1.62 |
Trailing EPS (TTM)
$-0.54
Forward EPS (Est.)
$-1.35
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.10 |
| 2024-12-31 | -1.93 |
| 2023-12-31 | 0.03 |
